vs
BioNexus Gene Lab Corp（BGLC）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
Arcadia Biosciences, Inc.的季度营收约是BioNexus Gene Lab Corp的1.9倍（$901.0K vs $483.8K），Arcadia Biosciences, Inc.净利率更高（-148.3% vs -214.2%，领先65.9%），Arcadia Biosciences, Inc.同比增速更快（-25.8% vs -80.8%），过去两年Arcadia Biosciences, Inc.的营收复合增速更高（-4.5% vs -54.9%）
BioNexus Gene Lab Corp是一家生物技术企业，主营分子诊断检测、基因分析及相关生命科学解决方案，服务客户涵盖医疗机构、科研机构及个人用户，核心市场主要覆盖东南亚地区。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
BGLC vs RKDA — 直观对比
营收规模更大
RKDA
是对方的1.9倍
$483.8K
营收增速更快
RKDA
高出55.0%
-80.8%
净利率更高
RKDA
高出65.9%
-214.2%
两年增速更快
RKDA
近两年复合增速
-54.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $483.8K | $901.0K |
| 净利润 | $-1.0M | $-1.3M |
| 毛利率 | -0.8% | 21.4% |
| 营业利润率 | -213.5% | -152.8% |
| 净利率 | -214.2% | -148.3% |
| 营收同比 | -80.8% | -25.8% |
| 净利润同比 | -197.5% | 67.1% |
| 每股收益（稀释后） | — | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BGLCRKDA
| Q4 25 | $483.8K | $901.0K | ||
| Q3 25 | $2.5M | $1.3M | ||
| Q2 25 | $2.3M | $1.5M | ||
| Q1 25 | $2.1M | $1.2M | ||
| Q4 24 | $2.5M | $1.2M | ||
| Q3 24 | $2.6M | $1.5M | ||
| Q2 24 | $2.0M | $1.3M | ||
| Q1 24 | $2.4M | $987.0K |
净利润BGLCRKDA
| Q4 25 | $-1.0M | $-1.3M | ||
| Q3 25 | $-709.0K | $856.0K | ||
| Q2 25 | $-616.2K | $-4.5M | ||
| Q1 25 | $-623.3K | $2.6M | ||
| Q4 24 | $-348.3K | $-4.1M | ||
| Q3 24 | $-1.3M | $-1.6M | ||
| Q2 24 | $199.1K | $1.1M | ||
| Q1 24 | $-103.8K | $-2.4M |
毛利率BGLCRKDA
| Q4 25 | -0.8% | 21.4% | ||
| Q3 25 | 14.8% | 32.1% | ||
| Q2 25 | 16.3% | 43.4% | ||
| Q1 25 | 16.1% | 43.2% | ||
| Q4 24 | 12.3% | 31.9% | ||
| Q3 24 | 12.4% | 32.9% | ||
| Q2 24 | 14.6% | 51.5% | ||
| Q1 24 | 15.3% | 52.3% |
营业利润率BGLCRKDA
| Q4 25 | -213.5% | -152.8% | ||
| Q3 25 | -27.6% | -88.5% | ||
| Q2 25 | -27.0% | -34.4% | ||
| Q1 25 | -28.9% | 44.2% | ||
| Q4 24 | -16.5% | -187.7% | ||
| Q3 24 | -50.9% | -114.5% | ||
| Q2 24 | 13.1% | — | ||
| Q1 24 | -3.3% | -160.9% |
净利率BGLCRKDA
| Q4 25 | -214.2% | -148.3% | ||
| Q3 25 | -27.9% | 65.7% | ||
| Q2 25 | -27.3% | -306.4% | ||
| Q1 25 | -29.2% | 216.6% | ||
| Q4 24 | -13.8% | -334.5% | ||
| Q3 24 | -51.1% | -104.9% | ||
| Q2 24 | 10.1% | 81.2% | ||
| Q1 24 | -4.4% | -245.5% |
每股收益（稀释后）BGLCRKDA
| Q4 25 | — | $-0.97 | ||
| Q3 25 | $-0.40 | $0.62 | ||
| Q2 25 | $-0.34 | $-3.26 | ||
| Q1 25 | $-0.04 | $1.90 | ||
| Q4 24 | $0.55 | $-2.99 | ||
| Q3 24 | $-0.75 | $-1.18 | ||
| Q2 24 | $0.11 | $0.78 | ||
| Q1 24 | $-0.01 | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.5M | $4.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $8.6M | $4.1M |
| 总资产 | $9.3M | $6.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BGLCRKDA
| Q4 25 | $2.5M | $4.6M | ||
| Q3 25 | — | $5.9M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $3.2M | ||
| Q4 24 | $2.9M | $4.2M | ||
| Q3 24 | — | $6.6M | ||
| Q2 24 | — | $8.1M | ||
| Q1 24 | — | $8.5M |
股东权益BGLCRKDA
| Q4 25 | $8.6M | $4.1M | ||
| Q3 25 | $6.8M | $5.4M | ||
| Q2 25 | $7.5M | $4.5M | ||
| Q1 25 | $7.8M | $8.9M | ||
| Q4 24 | $8.3M | $6.2M | ||
| Q3 24 | $9.4M | $10.3M | ||
| Q2 24 | $9.5M | $11.7M | ||
| Q1 24 | $9.3M | $10.6M |
总资产BGLCRKDA
| Q4 25 | $9.3M | $6.5M | ||
| Q3 25 | $7.6M | $8.6M | ||
| Q2 25 | $9.4M | $7.8M | ||
| Q1 25 | $9.5M | $13.0M | ||
| Q4 24 | $10.4M | $13.5M | ||
| Q3 24 | $11.0M | $15.2M | ||
| Q2 24 | $11.1M | $17.4M | ||
| Q1 24 | $11.2M | $16.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $961.1K | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | $960.1K | — |
| 自由现金流率自由现金流/营收 | 198.5% | — |
| 资本支出强度资本支出/营收 | 0.2% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.9M | — |
8季度趋势，按日历期对齐
经营现金流BGLCRKDA
| Q4 25 | $961.1K | $-861.0K | ||
| Q3 25 | $-1.2M | $-257.0K | ||
| Q2 25 | $-737.9K | $-2.0M | ||
| Q1 25 | $-824.1K | $-1.6M | ||
| Q4 24 | $219.2K | $-2.2M | ||
| Q3 24 | $-1.6M | $-1.8M | ||
| Q2 24 | $-672.3K | $-2.5M | ||
| Q1 24 | $-37.2K | $-3.2M |
自由现金流BGLCRKDA
| Q4 25 | $960.1K | — | ||
| Q3 25 | $-1.2M | — | ||
| Q2 25 | $-759.4K | — | ||
| Q1 25 | $-833.1K | — | ||
| Q4 24 | $215.2K | — | ||
| Q3 24 | $-1.8M | — | ||
| Q2 24 | $-674.1K | $-2.5M | ||
| Q1 24 | $-59.1K | $-3.2M |
自由现金流率BGLCRKDA
| Q4 25 | 198.5% | — | ||
| Q3 25 | -48.9% | — | ||
| Q2 25 | -33.6% | — | ||
| Q1 25 | -39.0% | — | ||
| Q4 24 | 8.5% | — | ||
| Q3 24 | -68.5% | — | ||
| Q2 24 | -34.1% | -188.3% | ||
| Q1 24 | -2.5% | -326.5% |
资本支出强度BGLCRKDA
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.2% | 0.0% | ||
| Q2 25 | 0.9% | 0.0% | ||
| Q1 25 | 0.4% | 0.0% | ||
| Q4 24 | 0.2% | 0.0% | ||
| Q3 24 | 7.6% | 0.0% | ||
| Q2 24 | 0.1% | 0.2% | ||
| Q1 24 | 0.9% | 1.3% |
现金转化率BGLCRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -3.38× | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
